Tessari Eben sold KNSA
August 18, 2025 · Form 4 insider transaction
Tessari Eben sold 100 shares of Kiniksa Pharmaceuticals International, plc at $34.44 per share, a transaction worth $3.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
100
Price
$34.44
Total value
$3.4K
InsiderTessari Eben
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateAugust 18, 2025
Filing dateAugust 20, 2025
Shares owned after40,215
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.